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Abstract The epithelial Ca
2? channels TRPV5/6 (tran-
sient receptor potential vanilloid 5/6) are thoroughly regu-
lated in order to ﬁne-tune the amount of Ca
2? reabsorption.
Calmodulin has been shown to be involved into calcium-
dependent inactivation of TRPV5/6 channels by binding
directly to the distal C-terminal fragment of the channels
(de Groot et al. in Mol Cell Biol 31:2845–2853, 12). Here,
we investigate this binding in detail and ﬁnd signiﬁcant
differences between TRPV5 and TRPV6. We also identify
and characterize in vitro four other CaM binding fragments
of TRPV5/6, which likely are also involved in TRPV5/6
channel regulation. The ﬁve CaM binding sites display
diversity in binding modes, binding stoichiometries and
binding afﬁnities, which may ﬁne-tune the response of the
channels to varying Ca
2?-concentrations.
Keywords Calmodulin  Multiple binding  Regulation 
TRP channels  TRPV5/6
Abbreviations
CaM Calmodulin
HSQC Heteronuclear single quantum coherence
ITC Isothermal titration calorimetry
TRPV5/6 Transient receptor potential vanilloid type 5/6
Introduction
The ubiquitous calcium sensor calmodulin (CaM) is known
to be a constitutive or dissociable Ca
2?-sensing subunit for
a large variety of ion channels including TRP family
channels, various ligand-gated and voltage-gated Ca
2?
channels [1]. Mounting evidence indicates that channel
regulation by calmodulin can involve multiple calmodulin
binding sites acting in concert [2], although at present little
is known about the functional role of the potential multiple
CaM molecules bound to a single functional channel.
One class of well-studied systems are the voltage-gated
Cav1-2 channels [3]. These channels contain several CaM
binding sites in their C-termini that are involved in the
regulation of the channel. The crystal structure of CaM
bound to the C-terminal fragment of the Cav1.2 channel has
previously been reported [4] and this prompted models for
explaining the role of CaM in CDI (calcium-dependent
inactivation) and CDF (calcium-dependent facilitation)
[5–7]. Subsequently, three additional CaM binding sites
have been identiﬁed in the N-terminus and in the loop
between transmembrane helices I and II [8]. Since their
interactions with CaM were characterized only in vitro it is
not clear whether these CaM binding sites are relevant in
vivo and hence what their functional role could be.
In TRP channels, which consist of 6 transmembrane
helices and intracellular N- and C-termini (Fig. 1), two
CaM binding sites have thus far been identiﬁed. However,
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exact role of calmodulin in their regulation [2]. For several
TRP channels binding of CaM to the C-terminal intracel-
lular part is reported to be crucial for calcium-dependent
inactivation [9, 10], but very few details about the molec-
ular mechanisms are available [11].
In our recent work [12], for the interaction between the
distalpartoftheC-terminusofTRPV5andCaM,weobserved
an unexpected 1:2 CaM:TRPV5 binding stoichiometry. We
proposedamodelwhichexplainedtheroleofCaMbindingin
calcium-dependent inactivationofthe TRPV5 channel.Here,
we present the details of the CaM binding to the distal part of
theC-terminusofTRPV5anditsclosehomologueTRPV6.In
addition, we also report the in vitro characterization of four
other CaM binding sites in TRPV5/6 channels and speculate
about their possible functional role.
Materials and methods
Peptide synthesis
Peptides corresponding to the amino acid residues 133–154,
310–330, 401–428, 591–612, 696–712 and 696–729 of
human TRPV5 and 401–428 and 690–716 of human
TRPV6 (cf. Table 1) were purchased from Peptides &
elephants GmbH (Potsdam, Germany) and GenicBio Lim-
ited (Shanghai, China). All peptides were puriﬁed by HPLC
([95% purity) and analyzed by mass-spectrometry. Prior to
all experiments, to remove residual TFA, the peptides were
dialyzed against an appropriate buffer (dialysis tubing
Spectra/Por
 7 with 1 K MWCO; Spectrum Labs, USA).
Protein expression and puriﬁcation
Recombinant Xenopus laevis calmodulin (identical to
mammalian) was expressed in E. coli AR58 cells carrying
the pTNcoI2 plasmid (kind gift of Dr. C. Klee, NIH,
Bethesda, MD, USA). Expression was induced by a tem-
perature shift from 30 to 42C and 3–4 h after induction
cells were harvested and lysed. Calmodulin was puriﬁed by
weak anion exchange (DEAE, GE Lifesciences) and afﬁnity
chromatography (Phenylsepharose, GE Lifesciences).
Puriﬁed protein was dialyzed against 1/100 of KCl 50 mM,
CaCl2 10 mM, Tris 20 mM pH 7.0, freeze-dried and stored
at -20C. Unless speciﬁed differently, all chemicals were
obtained from Sigma-Aldrich, USA). Uniformly
13C and/or
15N-labelled samples were produced by growing the cells in
M9 minimal medium containing 4 g/L
13C6-glucose and/or
1 g/L
15N-ammonium chloride (Buchem BV, Apeldoorn,
The Netherlands) as the sole source of carbon and/or
nitrogen, respectively.
NMR spectroscopy
For the titration by synthetic peptides,
15N-labeled CaM
sampleswithconcentration0.3–0.7 mMwereused.CaMand
peptidesweredissolvedineitherKCl50 mM,CaCl210 mM,
Tris 20 mM pH 7.0 (V5p1s, V6p1, V5p4, V5p5), or 10 mM
CaCl2, 10 mM ammonium acetate buffer pH 5.0 (V5p3 and
V6p3), or MilliQ water with 10 mM 2-mercaptoethanol
(V5p2 and V5p2n). Notably, upon dissolving the peptide
V5p2 in any buffer other than water precipitate was formed.
The experimental conditions for each peptide are sum-
marized in Table 1.
The binding of target peptides to CaM was monitored by
2D
15N-
1H-HSQC spectra. The combination of 1D
15N-
ﬁltered and 1D
15N-
1H-HSQC experiments was used to
assess the ratio of bound and non-bound peptides.
15N-
T1rho experiments were used to estimate the transverse
relaxation rates of the CaM resonances during the titration.
For sequential assignment of CaM 3D HNCACB and
CBCA(CO)NH experiments were performed.
All spectra were recorded at 308 K on Varian Inova
800 MHz or Bruker Avance III 600 MHz spectrometers,
each equipped with a cryogenic probe.
AllNMRspectrawereprocessedusingtheNMRpipesuite
[13] and analyzed by the program CcpNmr Analysis [14].
Fluorescence spectroscopy
Fluorescence measurements were performed using a Var-
ian Cary Eclipse ﬂuorescence spectrophotometer (Agilent
1 
2  3 
5 
4 
I  II III IV V  VI 
N
C
Fig. 1 Topology diagram of a typical TRP channel consisting of six
transmembrane domains and intracellular N- and C-termini. Predicted
CaM binding sites are numbered started from C-terminal side. V5p1
and V6p1 peptides correspond to the CaM binding site 1 of TRPV5
and TRPV6, respectively, as V5p2, V5p3/V6p3, V5p4 and V5p5
correspond to the CaM binding site 2, 3, 4 and 5 of TRPV5/6 (see also
Table 1)
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123Technologies, USA), with emission and excitation slit
width set to 5 nm. Tryptophan excitation wavelength was
set to 282 nm and emission spectra were recorded in the
range 295–405 nm. Each spectrum was recorded three
times and averaged. Fluorescence intensity contribution
from CaM and background intensity from buffer and
cuvettes were subtracted for each spectrum. The recorded
emission intensities were corrected for dilution effects. All
measurements were carried out at room temperature. CaM
and peptides stocks were prepared in 50 mM KCl, 10 mM
CaCl2 20 mM Tris pH 7.0 buffer. The concentration of
CaM in the samples was 5 lM, peptides were added up to a
CaM: peptide 2:1 molar ratio. For each titration point, the
samples were kept at room temperature for 30 min prior to
measurements to ensure that the equilibrium was reached.
Isothermal titration calorimetry (ITC)
ITC samples were prepared by dissolving CaM and pep-
tides in 50 mM KCl, 10 mM CaCl2, 20 mM Tris pH 7.0
buffer. The concentration of CaM in the cell was
15–20 lM, the concentration of peptides in the syringe
exceeded the CaM concentration by 15–20 times. Protein
concentrations were determined using a Nanodrop spec-
trophotometer ND-1000 (Isogen Life Science). ITC
experiments were carried out using an ITC200 device
(MicroCal Inc., Northampton, MA, USA). After thermal
equilibration at 298 K, thirty-nine 1 ll serial injections
were performed at 500 rpm stirring speed with an injection
spacing of 4 min. To correct the experimental binding
isotherm for background heat effects, we also titrated
peptide into buffer. All measurements were performed at
least three times to determine the optimal experimental
conditions with respect to signal-to-noise ratio. In all cases,
experiments were consistent and reproducible. ITC data
analysis was performed using the Origin 7.0 software
supplied by the manufacturer of the ITC. All data were
analyzed with ‘‘one binding site model’’ and the
‘‘sequential binding site model’’ implemented in this soft-
ware package.
Results
Identiﬁcation of CaM binding sites and peptide
synthesis
We ﬁrst identiﬁed potential CaM binding sites within
TRPV5/6 by in silico prediction using the calmodulin tar-
get database server [15]. Two CaM binding sites at the
TRPV5 C-terminus and one binding site at the TRPV6
C-terminus had been already reported [12, 16] and were
correctly identiﬁed by the server. In total, ﬁve predicted
binding sites (Fig. 1 and Supplementary Fig. 1s) were
chosen for in vitro characterization and the corresponding
synthetic human TRPV5/6 peptides were obtained. The
details regarding these ﬁve peptides are summarized in
Table 1.
Binding of CaM to the TRPV5 C-terminal peptide 1
In our previous work [12] we studied a long version of the
C-terminal TRPV5 peptide 1 (V5p1, residues 696–729 in
human TRPV5). Subsequent pull-down assays showed that
C-terminal deletion of 17 amino acids (yielding V5p1s,
residues 696–712 in human TRPV5) did not affect TRPV5
binding to CaM-Sepharose (S. Verkaart, private commu-
nication), so we ﬁrst decided to conﬁrm this observation in
vitro using various other biophysical assays.
High-resolution NMR-spectroscopy provides for a
detailed residue-speciﬁc assessment of CaM-peptide
interactions. Three
15N-
1H-HSQC spectra of the complexes
of CaM with V5p1s at molar ratios CaM:peptide 1:0/1:1/
1:2 are displayed superimposed in Fig. 2a. Notably, for
several residues the peak positions at 1:2 molar ratio (blue
spectrum) are distinct from those at 1:1 molar ratio (red
spectrum), which implies two binding events, as was also
observed for the longer peptide.
Using triple-resonance heteronuclear NMR experiments
and the previously published assignment of CaM (BMRB
entry 547), we rapidly established the backbone assignment
of CaM under the current conditions. Based on this CaM
sequential assignment, we determined that mainly the res-
idues from C-domain of CaM (81–149) are involved in the
ﬁrst binding event (Fig. 2c). Interestingly, increasing the
peptide concentration up to 1:2 molar ratio mainly caused a
shift of the resonances in the spectrum for the residues from
the N-domain of CaM (1–79). Further addition of the pep-
tide caused only minor changes including shifting of the
equilibrium towards the 1:2 complex (data not shown).
We next tested V5p1s peptide binding using ITC. Fig-
ure 3a shows the integrated heat pulses when titrating
V5p1s to CaM, together with a ﬁtted curve (red). The best
ﬁtting results were obtained using the ‘‘sequential binding
sites model’’. This model accounts for the non-indepen-
dence of the individual peptide-binding events and sug-
gests the number of binding sites before the ﬁtting, which
in this case was set to two. In accordance with the NMR
data, the ITC results indicate two distinct events with
macroscopic binding constants difference of approximately
three orders of magnitude (cf. Table 2).
The V5p1s peptide contains a single tryptophan residue
(W701) that has been implicated in direct interaction with
CaM [12]. The steady state tryptophan ﬂuorescence of
W701 was monitored upon addition of CaM (Fig. 4a). A
clear blue-shift of the emission maximum upon
94 N. V. Kovalevskaya et al.
123CaM-peptide complex formation was observed, consistent
with a more hydrophobic environment of the tryptophan
upon binding CaM. The extent of this blue-shift was
dependent on the amount of CaM added, with the most
hydrophobic environment (kmax * 324 nm) at a pep-
tide:CaM ratio of 1:2, which would correspond to a state in
which all peptide is predominantly bound to the high-
afﬁnity CaM site.
Binding of CaM to the TRPV6 C-terminal peptide 1
Close homologues TRPV5 and TRPV6 share 75% overall
amino acid sequence identity and have been shown to form
heteromeric complexes [17]. Previous investigations [9]
showed that the ﬁnal *30 amino acids of TRPV6 contain a
CaM binding site and that calcium-dependent channel
inactivation is enabled by CaM binding to this fragment.
These distal C-terminal CaM binding sites of TRPV5 and
TRPV6 channels, however, have only *43% sequence
identity. This raised the question whether CaM-binding to
these peptide regions occurs in a similar fashion in TRPV5
and TRPV6.
Figure 2b displays the
15N-
1H-HSQC spectra of CaM
upon titration by the V6p1 peptide. As also observed for
V5p1s, for many CaM residues two peaks of equal inten-
sity are observed at CaM:peptide ratio 1:1 (red spectrum).
One of these peaks corresponds to free Ca
2?/CaM, the
second one—to the peptide-bound form. For the CaM
residues K115 and T117 there are four peaks present. Upon
further addition of V6p1 peptide up to 1:2 molar ratio (blue
spectrum), all double peaks collapse into single ones
positioned exactly where the peptide-bound peak originally
H (ppm)
1 H (ppm)
1
6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5
105
110
115
120
125
130
6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5
105
110
115
120
125
130
 
N
 
(
p
p
m
)
1
5
 
N
 
(
p
p
m
)
1
5
A B
C
D
H (ppm)
1
 
N
 
(
p
p
m
)
1
5
6.5 7.0 7.5 8.0 8.5 9.0 9.5 10.0 10.5
105
110
115
120
125
130
T117
G33
I27
I100
N137
I130
A57
K21
T29
G134
L116
T117
G33
G134
I27
T29
L116
K115
N137
I100 I130
A57
K21
0    0.05          0.1             0.15   0.2      0.25            0.3                
Chemical shift change (ppm)
V5p1s
80
1
149
80
149
1
V6p1
r
e
s
i
d
u
e
 
n
u
m
b
e
r
r
e
s
i
d
u
e
 
n
u
m
b
e
r
N
C
N
C
Fig. 2 Overlaid
15N-
1H-HSQC CaM-peptide NMR spectra and data
analysis. Five to ten contours were deliberately spaced closely to
allow for proper overlaying of the spectra and emphasis of the
changes. a CaM-V5p1s spectra at CaM:V5p1s 1:0 (black), 1:1 (red)
and 1:2 (blue) molar ratio. b CaM-V6p1 spectra at CaM:V6p1 1:0
(black), 1:1 (red) and 1:2 (blue) molar ratio. c Chemical shifts
induced by the peptide as a function of CaM residue number at CaM-
peptide 1:1 (red) and 1:2 (blue) molar ratio. d CaM-V5p1s (dark blue)
and CaM-V6p1 (teal) spectra at 1:2 CaM:peptide molar ratio
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123appeared. Remarkably, in sharp contrast to V5p1s residues
from both domains of CaM are involved in the ﬁrst and the
second binding events of V6p1 (Fig. 2c). The state of the
peptide was also monitored by 1D
15N-ﬁltered experiments
(Supplementary Fig. 2s), which clearly established the 1:2
CaM:V6p1 binding stoichiometry.
The spectra of CaM with V5p1s and V6p1 at a molar
ratio of 1:2 are displayed overlaid in Fig. 2d. The spectra
are signiﬁcantly distinct from each other, thus suggesting a
differential organization of the two complexes.
The ITC data for the titration of CaM by the V6p1
peptide is shown in Fig. 3b. Again, the ﬁtting was per-
formed using the ‘‘sequential binding sites model’’, in order
to compare the data with those obtained for the V5p1s
peptide. For the V6p1 peptide, both binding events have
indistinguishable macroscopic binding constants, which are
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Fig. 3 ITC data for the titration
of CaM by V5p1s (a) and V6p1
(b). Integrated heat pulses and
curves (red) ﬁtted using
‘‘sequential binding sites
model’’ are shown for each
peptide. The resulting
thermodynamic parameters are
listed in Table 2
Table 2 ITC data for CaM titration by V5p1s and V6p1
Peptide K1 (M
-1)K 2 (M
-1) DH1
(kcal mol
-1)
DH2
(kcal mol
-1)
DS1
(cal mol
-1 deg
-1)
DS2
(cal mol
-1 deg
-1)
N
V5p1s
a 9.2 (±4.1) 9 10
6 2.9 (±1.9) 9 10
4 -38.0 ± 0.6 -25.2 ± 0.9 -95.3 -64.1 2
V6p1
a 2.2 (±1.7) 9 10
6 5.2 (±1.5) 9 10
6 -17.5 ± 0.9 -19.0 ± 0.8 -29.6 -33.0 2
V6p1
b 1.3 (±0.3) 9 10
7 – -18.0 ± 1.9 – -27.7 – 2.12 ± 0.01
a Sequential binding sites model; N is ﬁxed to the value 2
b One binding site model; N is allowed to vary
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Fig. 4 Tryptophan ﬂuorescence spectra of the peptides V5p1s (a), V6p1 (b) and V5p2 (c) in response to titration by CaM. Peptide:CaM ratios
1:0 (black), 1:0.5 (red), 1:0.75 (orange), 1:1 (green), 1:1.5 (light-blue) and 1:2 (dark blue)
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123similar in magnitude to the binding constant of the high-
afﬁnity V5p1s binding event (cf. Fig. 3a; Table 2). Fitting
the ITC data using the ‘‘one binding site model’’ (ﬁtted data
not shown) resulted in very similar values as obtained using
the ‘‘sequential binding sites’’ model (cf. Table 2). Notably,
while the thermodynamic parameters are essentially the
same between the two models, this second ﬁtting conﬁrmed
the 1:2 stoichiometry of the CaM to V6p1 binding.
Analogous to the V5p1s peptide, the V6p1 peptide also
contains a tryptophan residue (W695). Tryptophan ﬂuores-
cence spectra of V6p1 in the absence and the presence of
different amounts ofCa
2?/CaM are displayedinthe Fig. 4b.
Similar to V5p1s (Fig. 4a), we observed a blue-shift in
emission maximum upon CaM-peptide complex formation.
However,forV6p1 thereisagradual change ofthe emission
maximum from 358 to 324 nm upon addition of CaM.
Binding of CaM to the C-terminal peptide 2
The sequence corresponding to CaM binding site 2 (V5p2;
cf. Table 1; residues 591–612 in human TRPV5) located at
the beginning of the C-terminus is highly conserved among
all TRP channels (see Supplementary Fig. 1s). It is known
that the region ﬂanking (or even overlapping with) this CaM
binding site binds other molecules, including phosphati-
dylinositol-4,5-bisphosphate, Rab11a, 80K-H, BSPRY,
S100A10/annexin 2 complex, and NHERF4 [18].
In vitro binding of CaM to the peptide corresponding to
residues 587–616 of TRPV5 was previously established
using ﬂuorescence spectroscopy [16] and the equilibrium
dissociation constant of peptide/Ca
2?-CaM complex was
estimated to be 0.31 ± 0.02 lM. Holakovska et al. mod-
eled the structure of the complex based on known struc-
tures of CaM with peptides at canonical 1:1 molar ratio.
Since there was no experimental data about the stoichi-
ometry of binding of this peptide to calmodulin and given
our unexpected results for the V5/6p1 peptides, we decided
to check the binding of this proximal C-terminal fragment
with calmodulin for possible unusual properties.
15N-
1H-HSQC spectra of the complexes of CaM with
V5p2 at molar ratios 1:0 (black), 1:0.75 (red) and 1:1.5
(blue) are presented in Fig. 5a. At the concentrations
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Fig. 5
15N-
1H-HSQC CaM-peptide NMR spectra and data analysis.
Five to ten contours were deliberately spaced closely to allow for
proper overlaying of the spectra and emphasis of the changes. a CaM-
V5p2 spectra at CaM:V5p1s 1:0 (black), 1:0.75 (red) and 1:1.5 (blue)
molar ratio. b CaM-V5p3 spectra at CaM:V5p3 1:0 (black) and 1:1
(red) molar ratio. c CaM-V5p4 spectra at CaM:V5p4 1:0 (black), 1:1
(red), 1:2 (blue) and 1:3 (green) molar ratio. d CaM-V5p5 spectra at
CaM:V5p5 1:0 (black), 1:1 (red), 1:2 (blue) and 1:3 (green) molar
ratio
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123desired for NMR spectroscopy, V5p2 was only soluble in
H2O, and thus NMR samples were prepared in 95:5 v:v
H2O/D2O with 10 mM 2-mercaptoethanol.
At CaM:V5p2 1:0.75 molar ratio, a signiﬁcant number of
the CaM peaks are doubled and for some peaks substantial
line broadening is observed. At 1:1.5 molar ratio, many
peaks are signiﬁcantly broadened, some even beyond
detection, whereas for other residues multiple peaks corre-
spondingtoboundCaMareobserved.Tocheckforpotential
aggregation induced by the peptide, we recorded
15N-T1rho
(spin–lattice relaxation time in the rotating frame) experi-
ments which directly confer information regarding the
rotational diffusion of the molecule and hence the oligo-
meric state. Using the envelope of the well-dispersed,
upﬁeld-shifted amide resonances, we obtained T1rho values
of *100 ms for free Ca
2?/CaM which decreased to
*80 ms for CaM in the 1:1.5 complex. These values are
consistent with a (predominantly) monomeric state of CaM.
Notably, the upﬁeld shifted resonances correspond to resi-
duesfrombothdomainsofCaM,sotheobservedbroadening
of the
15N-
1H-HSQC cross peaks is therefore most likely
caused by conformational exchange. The
15N-
1H-HSQC
spectra of CaM titrated by the V5p2n peptide featuring a
C611S mutation (to prevent possible disulﬁde bonds for-
mation)isdisplayedinSupplementaryFig. 3s.Analogousto
V5p2,atCaM:V5p2n1.0:1.5molarratioasigniﬁcantlossof
signal is observed and an intermediate exchange regime is
retained (cf. Fig. 5a). Hence, we exclude disulﬁde bond
formation to be responsible for the major differences
between V5p2/V5p2n and the other peptides.
As for the V5p1s and V6p1 peptides, we recorded
tryptophan ﬂuorescence spectra for the V5p2 peptide in the
absence and in the presence of different amounts of Ca
2?/
CaM, employing its single tryptophan residue (W593)
(Fig. 4c). A blue-shift in emission maximum was again
observed upon addition of CaM, but it only became
noticeable at CaM:peptide 0.75:1 molar ratio (shift from
350 to 337 nm). Further addition of CaM led to the emis-
sion maximum shift to 312 nm.
Due to the limited solubility of the V5p2 peptide we
were not able to obtain reproducible ITC data for its
interaction with CaM.
Binding of CaM to the transmembrane peptide 3
The loop between transmembrane helices 2 and 3 (residues
408–418, numbering for mouse TRPV6; TM23-loop) has
been shown to signiﬁcantly affect the kinetics of TRPV5
and TRPV6 channel inactivation [19]. TRPV6 to TRPV5
mutations of residues in this loop, i.e. L409V, V411A and
T412S in TRPV6, resulted in the conversion of the TRPV6
inactivation pattern to that of TRPV5. Interestingly, the
TM23-loop was predicted to bind CaM by our in silico
analysis and hence we decided to also check its CaM
binding properties.
Peptides corresponding to the TM23-loop of TRPV5 and
TRPV6 (V5p3 and V6p3, respectively) were only soluble at
pH 5.0 and therefore their binding with Ca
2?/CaM was
studied in 10 mM CaCl2, 10 mM ammonium acetate buffer
pH 5.0. Figure 5b displays the
15N-
1H-HSQC spectra of the
complexes of CaM with V5p3 at 1:0 and 1:1 molar ratio.
Addition of more peptide did not cause any further change
(supplementary Fig. 4sA). Residues of both CaM domains
were involved in the binding process, demonstrating a
classical1:1bindingmode.ForthetitrationofCaMbyV6p3
similar results were obtained(supplementary Fig. 4sB). The
binding patterns observed for CaM in the two complexes
were also very similar (supplementary Fig. 4sC). Low pH
(5.0) might inﬂuence CaM-peptide interactions but we have
not studied the effect of pH in details. As both peptides
contain neither tryptophan, nor tyrosine residues, ﬂuores-
cence measurements were not possible using the native
peptides. Unfortunately, solubility problems also prevented
the analysis of these peptides using ITC.
Binding of CaM to the N-terminal peptides 4 and 5
The in silico analysis also identiﬁed the sequences corre-
sponding to human TRPV5 residues 133–154 and 310–330
as potential CaM interaction peptides (denoted as V5p5 and
V5p4, respectively, cf. Table 1). Figure 5c and d shows
15N-
1H-HSQC spectra of
15N-labelled CaM recorded for
varying molar ratios of V5p4 and V5p5 peptides, respec-
tively. In both cases the gradual shift of the affected reso-
nances in response to increasing amounts of peptide
indicates that the complex is in fast exchange on the NMR
timescale, which is indicative for a relatively weak afﬁnity.
The selective nature of the shifting residues however,
indicates that these binding events are speciﬁc. Notably,
shifting of several resonances in the spectra of CaM titration
by V5p4 follows a curved trajectory, which indicates that
multiple processes take place during V5p4 binding to CaM.
The V5p4 peptide contains a single tryptophan residue
(W322) and could be studied by ﬂuorescence spectroscopy.
It behaves in much the same way as described above for the
peptides V5p1s, V6p1 and V5p2, demonstrating a blue
shift upon addition of calmodulin (supplementary Fig. 5s).
Discussion
Interactions of calmodulin with the C-terminal peptides
We previously characterized the long version of V5p1
peptide corresponding to the distal C-terminal CaM bind-
ing sequence in TRPV5 (residues 696–729 in human
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crucial for calcium-dependent channel inactivation. Dis-
ruption of the CaM binding site leads to a constitutively
open channel [12]. Here, we established that deletion of the
ﬁnal 17 amino acids does not alter the CaM binding
properties of this region and a shorter version of the peptide
(V5p1s; residues 696–712 of human TRPV5) proved better
amenable to biophysical studies. Indeed,
15N-
1H-HSQC
spectra of CaM titrated by the short peptide V5p1s
(Fig. 2a) are highly similar to the spectra of CaM titrated
by the long version of the peptide [12]. As observed for the
V5p1 long peptide, a 1:2 CaM:peptide binding stochiom-
etry was also observed for V5p1s. This stochiometry was
also conﬁrmed by the ﬂuorescence data (Fig. 4a) and the
ITC data (Fig. 3a) that displays two distinct binding events
with Ka values of 9.2 (±4.1) 9 10
6 M
-1 and 2.9 (±1.9) 9
10
4 M
-1, respectively (Table 2).
The CaM-V5p1s complex allowed for the identiﬁcation
of the CaM resonances in the
15N-
1H-HSQC spectra and
hence identiﬁcation of the residues involved in the binding.
Surprisingly, the ﬁrst, high-afﬁnity binding event mostly
involves the residues in the C-terminal domain of CaM,
whereas the second event affects mostly the residues of the
N-domain of CaM (Fig. 2c).
The TRPV6 is a close homolog of TRPV5, yet the
binding of V6p1 peptide displays remarkable differences.
The
15N-
1H-HSQC spectra recorded at varying stoichi-
ometries again indicate the formation of a 1:2 CaM:peptide
complex. However, in contrast to V5p1s, in the CaM-V6p1
spectra only two CaM peak positions are observed for each
residue. These correspond to the free Ca
2?/CaM and pep-
tide-bound CaM conformations. Exception to this are the
residues K115 and T117 that display four peaks at a 1:1
stochiometry indicating involvement of these residues in a
complex equilibrium and sensitivity to both binding events.
1D
15N-ﬁltered experiments (supplementary Fig. 2s) con-
ﬁrmed 1:2 binding stoichiometry as well as the ITC data
(Fig. 3b) when ﬁtted by the ‘‘one binding site model’’.
The binding of the V6p1 peptide to CaM is different
compared to the V5p1s binding. In sharp contrast to V5p1s,
both V6p1 binding events have nearly identical afﬁnities
(cf. Fig. 3 and Table 2). Moreover, while V5p1s demon-
strates two signiﬁcantly different binding events, with the
C-domain of CaM involved in the ﬁrst, high-afﬁnity event,
and N-domain of CaM in the second, lower-afﬁnity one,
binding of V6p1 involves both domains of CaM to a
similar extent (Fig. 2c). Comparison of the
15N-
1H-HSQC
spectra of the 1:2 complexes of CaM with V5p1s and V6p1
(Fig. 2d) also implies that the two complexes have a dif-
ferent structural organization.
TRPV5 and TRPV6 both can form functional homo- or
heteromeric complexes with different properties [17]. It is
tempting to speculate that the differential binding of CaM
to the C-terminal regions of these channels is the molecular
cause of some of their functional differences.
The V5p2 peptide, corresponding to the proximal CaM
binding site 2 (Fig. 1), demonstrates rather remarkable
behavior: while being soluble in water, it tends to aggre-
gate in aqueous buffer solutions and causes dramatic line
broadening in the CaM NMR spectra. To exclude the for-
mation of disulﬁde bridges by the single free cysteine in the
V5p2 peptide as cause of this behavior, we used substantial
amounts of 2-mercaptoethanol (10 mM) and tested the
same peptide where the cysteine residue was substituted
with a serine (V5p2n). Neither of these two conditions
appears to alter the observed behavior and the self-aggre-
gation of the peptide may be caused by its inherent pro-
pensity. Indeed, using the TANGO algorithm [20] the
VVATTVML segment of V5p2 yielded a b-aggregation
score comparable to that of b-amyloid peptides. Interest-
ingly, mutation of the tryptophan residue, which is likely to
be crucial for CaM binding, to alanine (W593A) led to the
formation of non-functional channels (S. Verkaart, private
communication), clearly also implicating the participation
of this region in the channel regulation.
Unfortunately, we were not able to obtain reproducible
ITC data for V5p2 interactions with CaM and hence con-
ﬁrm the Kd value 0.31 ± 0.02 lM measured in [16] using
steady-state ﬂuorescence anisotropy measurements of
ﬂuoresceinisothiocyanate labeled peptides.
Interactions of calmodulin with the transmembrane
and N-terminal peptides
We have demonstrated that the V5p3 and V6p3 peptides
containing the TM23-loop bind CaM in vitro in a 1:1
canonical manner. These peptides share 68% sequence
similarity and have ﬁfteen hydrophobic/positively charged/
bulky amino acids (I, L, V, F, Y, R), which together form
canonical CaM binding sites [15]. However, functionally
the TM23-loop is poorly characterized but has been
implicated in channel inactivation [19]. Amino acids
M410, V412 and T413 (numbering for human TRPV6),
which were shown to be responsible for fast TRPV6
inactivation [19], are all situated inside the CaM-binding
sequence and it is likely that CaM binding to this fragment
provides the molecular switch for this inactivation process.
N-terminal peptides V5p4 and V5p5 also bind CaM in
vitro as shown by NMR (V5p4 and V5p5) and ﬂuorescence
spectroscopy (V5p4). The V5p4 and V5p5 peptides dem-
onstrate weak but speciﬁc binding to CaM, in line with the
results for CaM-mediated interactions observed before [8].
Both peptide sequences are well conserved in eukaryotes
and share 81 and 68% sequence similarity, respectively.
There are several serine and threonine residues within these
two CaM-binding sites, which can be phosphorylated and
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123thus potentially could be involved in regulation, analo-
gously to the regulatory effects observed in the distal
C-terminal region of the TRPV5/6 channels [12]. Clearly,
more functional data is needed to reveal the full role of CaM
binding to TRPV5/6. Unfortunately, the multiple CaM
interaction sites in TRPV5/6 complicate the assessment of
in vivo interactions and their functional consequences.
Conclusion
We identiﬁed and characterized in vitro ﬁve CaM binding
sites in the TRPV5/6 channels. All the ﬁve sites bind cal-
modulin but display diversity in their binding modes,
binding stoichiometries and binding afﬁnities. Together,
they may allow for a complicated and ﬁnely tuned mech-
anism of TRPV5/6 channel (in)activation in response to
Ca
2?, in analogy to similar effects observed for the volt-
age-gated Cav1-2 channels.
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